Skip to main content
. 2017 Aug 4;38(6):489–515. doi: 10.1210/er.2017-00062

Figure 5.

Figure 5.

Schematic of a future precision medicine workflow. Top: Relevant factors for disease assessment. Middle: Recommendations presented on a precision medicine card based on whether the patient is disease free. Bottom: Future potential treatments for systemic disease. PARP, poly [ADP-ribose] polymerase; TKI; tyrosine kinase inhibitor.